VIP and pancreatic neuroendocrine tumor: The tumor of the prostate is diffusely positive for NKX3.1 (a prostate marker) and displays single-cell nuclear positivity for synaptophysin, but negativity for VIP and Islet‐1, a marker for pancreatic neuroendocrine tumors (PanNET).